TY - JOUR
T1 - Disruption of HIF-1α in hepatocytes impairs glucose metabolism in diet-induced obesity mice
AU - Ochiai, Daigo
AU - Goda, Nobuhito
AU - Hishiki, Takako
AU - Kanai, Mai
AU - Senoo-Matsuda, Nanami
AU - Soga, Tomoyoshi
AU - Johnson, Randall S.
AU - Yoshimura, Yasunori
AU - Suematsu, Makoto
N1 - Funding Information:
The authors thank Junko Amano from the Keio University animal care facility for assistance with breeding of H-HIFKO mice. Grant Support: D.O. was a research associate supported by Global COE Program for Human Metabolomic Systems Biology by MEXT, Japan. N.G. was supported in part by the “High-Tech Research Center” Project for Private Universities, with a matching fund subsidy from MEXT. Harvesting animals was supported by Research and Development of the Next-Generation Integrated Simulation of Living Matter, a part of the Development and Use of the Next-Generation Supercomputer Project of MEXT.
PY - 2011/11/25
Y1 - 2011/11/25
N2 - The liver plays a central role in glucose homeostasis in the whole-body by responding to environmental factors including nutrients, hormones, and oxygen. In conditions of metabolic overload such as diabetes mellitus and obesity, coordinated regulation between oxygen supply and consumption has been reported to be disrupted and subsequently cause tissue hypoxia, although pathological significance of the disease-related hypoxia remains elusive. To investigate the role of tissue hypoxia in the liver on systemic glucose homeostasis, mice lacking HIF-1α gene, a critical component of a master regulator of hypoxic response, in hepatocytes were exposed to high fat/sucrose diet (HFSD). Exposure to HFSD for 5. weeks elicited liver hypoxia with a transient increase in HIF-1α protein expression in the liver of control mice. Glucose disposal was marginally impaired in control mice when challenged oral glucose tolerance test, but such impairment was enhanced in the mutant mice. This alteration was accompanied by a complete inhibition of glucokinase induction with a significant reduction of hepatic glucose uptake. Mice fed HFSD for 20. weeks exhibited fasting hyperglycemia and glucose intolerance, whereas these metabolic phenotypes deteriorated considerably with severe insulin resistance in skeletal muscles and adipose tissues in the mutant mice. These findings suggest that HIF-1 in hepatocytes plays protective roles against the progression of diabetes mellitus.
AB - The liver plays a central role in glucose homeostasis in the whole-body by responding to environmental factors including nutrients, hormones, and oxygen. In conditions of metabolic overload such as diabetes mellitus and obesity, coordinated regulation between oxygen supply and consumption has been reported to be disrupted and subsequently cause tissue hypoxia, although pathological significance of the disease-related hypoxia remains elusive. To investigate the role of tissue hypoxia in the liver on systemic glucose homeostasis, mice lacking HIF-1α gene, a critical component of a master regulator of hypoxic response, in hepatocytes were exposed to high fat/sucrose diet (HFSD). Exposure to HFSD for 5. weeks elicited liver hypoxia with a transient increase in HIF-1α protein expression in the liver of control mice. Glucose disposal was marginally impaired in control mice when challenged oral glucose tolerance test, but such impairment was enhanced in the mutant mice. This alteration was accompanied by a complete inhibition of glucokinase induction with a significant reduction of hepatic glucose uptake. Mice fed HFSD for 20. weeks exhibited fasting hyperglycemia and glucose intolerance, whereas these metabolic phenotypes deteriorated considerably with severe insulin resistance in skeletal muscles and adipose tissues in the mutant mice. These findings suggest that HIF-1 in hepatocytes plays protective roles against the progression of diabetes mellitus.
KW - Carbohydrate metabolism
KW - Diabetes
KW - Glucokinase
KW - HIF-1
KW - Hypoxia
KW - Liver
UR - http://www.scopus.com/inward/record.url?scp=82355191512&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=82355191512&partnerID=8YFLogxK
U2 - 10.1016/j.bbrc.2011.10.089
DO - 10.1016/j.bbrc.2011.10.089
M3 - Article
C2 - 22051049
AN - SCOPUS:82355191512
SN - 0006-291X
VL - 415
SP - 445
EP - 449
JO - Biochemical and Biophysical Research Communications
JF - Biochemical and Biophysical Research Communications
IS - 3
ER -